Answers are grounded in this paper and cite their sources.
HMGB-1 was more strongly expressed in SF of RA patients than in that of OA patients, inducing the release of proinflammatory cytokines from SFMs. HMGB-1 plays a pivotal role in the pathogenesis of RA and may be an original target of therapy as a novel cytokine.
No takes yet. Share an insight, caveat, or question.
Taniguchi et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: